Issuance planned for 92,858 new investment units via general public offering and 4,642 units via secondary offering. Total amount is undecided; issue price will be determined on the pricing date, and the public offering price will be set in the range of closing price \u00d7 0.90\u20131.00. Funds will be used for acquisition of assets, among other purposes.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3455","jir_company_name":"Health Care & Medical Investment Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-19","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3455-20260819-01.pdf","jir_short_summary":"Issuance planned for 92,858 new investment units via general public offering and 4,642 units via secondary offering. Total amount is undecided; issue price will be determined on the pricing date, and the public offering price will be set in the range of closing price \u00d7 0.90\u20131.00. Funds will be used for acquisition of assets, among other purposes.","jir_summary":"### Overview\nThe REIT has decided to conduct a new issuance of investment units and a secondary offering. General public offering of new investment units is planned at 92,858 units, and secondary offering at 4,642 units. The issue price and offer price will be determined after the determination date, and general public offering will be underwritten by SMBC Nikko Securities, Nomura Securities, and SBI-SCS Securities. A third-party allocation of new investment units is also planned, with total issued investment units expected to be up to 457,000 units.\n\n### Use of funds and Outlook\nTotal funds raised are expected to be up to 1,010,000,000 yen (general offering proceeds of 9,610,000,000 yen plus up to 490,000,000 yen from third-party allocation). Proceeds from the general offering will be allocated to asset acquisition funds, with the remaining amount to be used as working capital, future asset acquisition funds, or debt repayment. Future operational results and related matters will be announced separately.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#HealthcareAssetManagement, #CapitalPolicy, #NewInvestmentUnitIssuance, #InvestmentUnitSecondaryOffering","jir_key_figures":"General offering units: 92,858 units\nSecondary offering units: 4,642 units\nUpper limit of funds raised: 10,100,000,000 yen\nTotal issued investment units (current): 359,500 units\nTotal issued after general offering: 452,358 units\nIncrease in new investment units from third-party allocation: 4,642 units\nTotal issued after third-party allocation: 457,000 units","jir_meta_title":"Health Care & Medical Investment Corporation: Resolution on New Investment Unit Issuance and Secondary Offering | August 2026","jir_meta_description":"Health Care & Medical Investment Corporation plans to publicly issue 92,858 new investment units and offer 4,642 units via secondary offering. Issue price and offer price will be decided on the date of determination. Funds will be used for asset acquisition funds, etc. This provides the latest capital policy information.","jir_og_title":"Health Care & Medical Investment Corporation: Resolution on New Investment Unit Issuance and Secondary Offering","jir_og_description":"Health Care & Medical Investment Corporation plans to implement 92,858 new investment units and 4,642 units via secondary offering. Issue price and offer price will be determined on the date of determination. Funds will be allocated to asset acquisition funds.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17572,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-105346","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n